Barely Significant
← all excerpts

Dual-Targeted Zeolitic Imidazolate Frameworks Drug Delivery System Reversing Cisplatin Resistance to Treat Resistant Ovarian Cancer.

Int J Nanomedicine · 2024 · PMC11230133 · PMID 38979533

Europe PMCDOI
1
hedged sentence
0.0010
closest p · 0.0× alpha
0.0010
boldest claim

The sentences

moderately significantp < 0.001actually significant
Statistically significance was set ns (not significantDP), *p < 0.05 (significant), **p < 0.01 (moderately significant), and ***p < 0.001 (highly significant).

also in 2,182 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.